Community Academic Profiles–

Jerome Yesavage

Back to Profile

Publication Details

  • Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.

    Brooks JO, Yesavage JA, Carta A, Bravi D. Int Psychogeriatr. 1998; 10 (2): 193-203

    To assess the longitudinal effects of acety-L-carnitine (ALC) on patients diagnosed with Alzheimer's disease.

    PubMedID: 9677506

Stanford Medicine Resources:

Footer Links: